CTLA4 and rheumatoid arthritis: Over the last 30 years, the treatment of rheumatoid arthritis (RA) has been revolutionized with the development of biologic therapies such as anti-TNF, anti-IL-6, CTLA4-Ig and anti-CD20 agents, among others.